Roivant Sciences

8 Decision Makers · 11 Verified Contacts & Email Format

📍 New York, NYPharmaceuticals🗓 Est. 2014👥 501–1000 employees

About Roivant Sciences

Roivant Sciences is a biopharmaceutical company focused on the development of medicines and healthcare technologies to patients.

Email Format

{first_name}.{last_name}@roivant.com — 100.0%

sarah.smith@roivant.com

Leadership & Decision Makers

Contact details of 8 Roivant Sciences decision makers

Matthew Gline

Chief Financial Officer LinkedIn
  • Work email

    m***********e@roivant.com

Tanya Shaby

Partner, Legal LinkedIn
  • Work email

    t*********y@roivant.com

Vivek Ramaswamy

Founder and Executive Chairman

Mayukh Sukhatme

Chief Investment Officer & President

Benjamin Zimmer

President, Roivant Health

Dan Rothman

Chief Information Officer

Celine Chan

Chief Information Security Officer

Eric Venker

President and Chief Operating Officer

Team & Specialists

Contact details of 3 Roivant Sciences team members

Jamie Schiff

Software Engineer LinkedIn
  • Work email

    j**********f@roivant.com

Woody Sherman

  • Work email

    w***********n@roivant.com

Frank Torti

Vant Chair

General Emails

General company emails, e.g. customer support lines

    info@roivant.com

    General Inquiries

    alan.roemer@roivant.com

    Unclassified inbox

Similar Companies like Roivant Sciences

Loxo Oncology

loxooncology.com
Pharmaceuticals · New York, NY · Est. 2013 · 501–1000 employees

HQ: New York, NY

Biotechnology · New York, NY · Est. 1849 · Above 10001 employees

HQ: New York, NY

Biotechnology · New York, NY · Est. 1887 · Above 10001 employees

HQ: New York, NY

Jazz Pharmaceuticals

jazzpharma.com
Biotechnology · Palo Alto, CA · Est. 2003 · 501–1000 employees · $500M–$1B

HQ: Palo Alto, CA

Explore similar firms in the Pharmaceuticals sector

Company Info

Last updated: 27/07/2025

+44 2074003347

New York, NY

Specialization: Biopharmaceutical, Product Research,
Legal Name: Roivant Sciences Ltd.
Business Type: Public
Employees: 501-1000
Rounds: Post-IPO Equity
Founded Date: May 2014
Number of Exits: 2
Company Type: For Profit
Stock Symbol: NASDAQ:ROIV
Operating Status: Active
Last Funding Type: Post-IPO Equity
Phone Number: +44 2074003347
Last Investment Activity: Mar 25, 2024
Investments Activity: Mar 25, 2024 Feb 13, 2024 Jan 5, 2024

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.